Use of radiofrequency ablation of the vaginal canal for genitourinary syndrome of menopause: a prospective cohort study with 12-month follow-up

20250 citationsJournal Article

Authors

Rodger Rothenberger · University of Louisville

Elaine Kopinga · Pelvic & Sexual Health Institute

Jeffrey R. Dell · Female Pelvic Medicine Institute of Virginia

Robert D. Moore · Moore College of Art and Design

John R. Miklos · Moore College of Art and Design

Mickey M. Karram · Christ Hospital

Abstract

This study suggests that radiofrequency ablation of the vaginal canal by the MorpheusV applicator is a safe and effective intervention for GSM to 12 months post-treatment.

Topics & Keywords

Menopause: Health Impacts and Treatments Pelvic floor disorders treatments Dermatology and Skin Diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Menopause The Journal of The North American Menopause Society

Volume 32, Issue 9, pp. 858-863

DOI: 10.1097/gme.0000000000002564

Field-Weighted Citation Impact: 0.00